Fremont, CA, United States of America

Felice C Lightstone

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 9.8

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2020

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: Pioneering Inventor Felice C Lightstone: Revolutionizing Antibacterial Medicines

Introduction:

Diving into the world of groundbreaking innovations, the inventive mind of Felice C Lightstone shines brightly as he spearheads advancements in antibacterial medicines. Hailing from Fremont, CA, US, Lightstone has left an indelible mark with his inventive prowess, holding an impressive portfolio of 7 patents to his name.

Latest Patents:

Lightstone's recent patents delve into the realm of tricyclic gyrase inhibitors, presenting compounds of Formula I and their derivatives as potent antibacterial agents. With a focus on enhancing efficacy and combatting microbial resistance, these inventions showcase Lightstone's commitment to advancing antibiotic therapies. Pharmaceutical compositions, uses, and manufacturing processes associated with these compounds further underscore his innovative vision.

Career Highlights:

Having traversed reputable organizations, Lightstone's expertise has been instrumental at Lawrence Livermore National Security, LLC and Merck Sharp & Dohme Corporation. His contributions have not only shaped the landscape of pharmaceutical research but have also paved the way for transformative solutions in healthcare.

Collaborations:

In his quest for innovation, Lightstone has collaborated with esteemed professionals in the field, including the likes of Sergio E Wong and Daniel Benson. Together, they have synergized their skills to drive forward pioneering research initiatives and catalyze impactful discoveries.

Conclusion:

In conclusion, Felice C Lightstone stands as a beacon of innovation, bridging the gap between scientific ingenuity and tangible healthcare solutions. His dedication to revolutionizing antibacterial medicines underscores a profound commitment to societal well-being, making him a stalwart figure in the realm of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…